The Market Reports

Index

1 Market Overview
1.1 Radiopharmaceuticals in Nuclear Medical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceuticals in Nuclear Medical Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceuticals in Nuclear Medical Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 Global Radiopharmaceuticals in Nuclear Medical Market Size & Forecast
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume (2017-2028)
1.4.3 Global Radiopharmaceuticals in Nuclear Medical Price (2017-2028)
1.5 Global Radiopharmaceuticals in Nuclear Medical Production Capacity Analysis
1.5.1 Global Radiopharmaceuticals in Nuclear Medical Total Production Capacity (2017-2028)
1.5.2 Global Radiopharmaceuticals in Nuclear Medical Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Radiopharmaceuticals in Nuclear Medical Market Drivers
1.6.2 Radiopharmaceuticals in Nuclear Medical Market Restraints
1.6.3 Radiopharmaceuticals in Nuclear Medical Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
2.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Cambridge Isotope Laboratories
2.2.1 Cambridge Isotope Laboratories Details
2.2.2 Cambridge Isotope Laboratories Major Business
2.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product and Services
2.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cardinal Health
2.3.1 Cardinal Health Details
2.3.2 Cardinal Health Major Business
2.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product and Services
2.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Product and Services
2.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eczacibasi-Monrol
2.5.1 Eczacibasi-Monrol Details
2.5.2 Eczacibasi-Monrol Major Business
2.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product and Services
2.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Fujifilm Holdings Corporation
2.6.1 Fujifilm Holdings Corporation Details
2.6.2 Fujifilm Holdings Corporation Major Business
2.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
2.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GE Healthcare (Subsidiary Of General Electric Company)
2.7.1 GE Healthcare (Subsidiary Of General Electric Company) Details
2.7.2 GE Healthcare (Subsidiary Of General Electric Company) Major Business
2.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product and Services
2.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 IBA Group
2.8.1 IBA Group Details
2.8.2 IBA Group Major Business
2.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Product and Services
2.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Lantheus Medical Imaging
2.9.1 Lantheus Medical Imaging Details
2.9.2 Lantheus Medical Imaging Major Business
2.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
2.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Nordion
2.10.1 Nordion Details
2.10.2 Nordion Major Business
2.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Product and Services
2.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Ntp Radioisotopes
2.11.1 Ntp Radioisotopes Details
2.11.2 Ntp Radioisotopes Major Business
2.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product and Services
2.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Siemens Healthcare
2.12.1 Siemens Healthcare Details
2.12.2 Siemens Healthcare Major Business
2.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product and Services
2.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Taiyo Nippon Sanso Corporation
2.13.1 Taiyo Nippon Sanso Corporation Details
2.13.2 Taiyo Nippon Sanso Corporation Major Business
2.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
2.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Urenco Limited
2.14.1 Urenco Limited Details
2.14.2 Urenco Limited Major Business
2.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product and Services
2.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Rotem Industries
2.15.1 Rotem Industries Details
2.15.2 Rotem Industries Major Business
2.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product and Services
2.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Radiopharmaceuticals in Nuclear Medical Breakdown Data by Manufacturer
3.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Radiopharmaceuticals in Nuclear Medical
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceuticals in Nuclear Medical Manufacturer Market Share in 2021
3.4.2 Top 6 Radiopharmaceuticals in Nuclear Medical Manufacturer Market Share in 2021
3.5 Global Radiopharmaceuticals in Nuclear Medical Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Radiopharmaceuticals in Nuclear Medical Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Region
4.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume by Region (2017-2028)
4.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Region (2017-2028)
4.2 North America Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028)
4.3 Europe Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028)
4.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028)
4.5 South America Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028)
4.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume by Type (2017-2028)
5.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2017-2028)
5.3 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume by Application (2017-2028)
6.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Application (2017-2028)
6.3 Global Radiopharmaceuticals in Nuclear Medical Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
7.2 North America Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
7.3 North America Radiopharmaceuticals in Nuclear Medical Market Size by Country
7.3.1 North America Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028)
7.3.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
8.2 Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
8.3 Europe Radiopharmaceuticals in Nuclear Medical Market Size by Country
8.3.1 Europe Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028)
8.3.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
9.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
9.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
10.2 South America Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
10.3 South America Radiopharmaceuticals in Nuclear Medical Market Size by Country
10.3.1 South America Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028)
10.3.2 South America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
11.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
11.3 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Radiopharmaceuticals in Nuclear Medical and Key Manufacturers
12.2 Manufacturing Costs Percentage of Radiopharmaceuticals in Nuclear Medical
12.3 Radiopharmaceuticals in Nuclear Medical Production Process
12.4 Radiopharmaceuticals in Nuclear Medical Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Radiopharmaceuticals in Nuclear Medical Typical Distributors
13.3 Radiopharmaceuticals in Nuclear Medical Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medical Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Radiopharmaceuticals in Nuclear Medical Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
Table 6. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Cambridge Isotope Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Cambridge Isotope Laboratories Major Business
Table 9. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product and Services
Table 10. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 12. Cardinal Health Major Business
Table 13. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product and Services
Table 14. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Medtronic Basic Information, Manufacturing Base and Competitors
Table 16. Medtronic Major Business
Table 17. Medtronic Radiopharmaceuticals in Nuclear Medical Product and Services
Table 18. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Eczacibasi-Monrol Basic Information, Manufacturing Base and Competitors
Table 20. Eczacibasi-Monrol Major Business
Table 21. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product and Services
Table 22. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Fujifilm Holdings Corporation Major Business
Table 25. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
Table 26. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Manufacturing Base and Competitors
Table 28. GE Healthcare (Subsidiary Of General Electric Company) Major Business
Table 29. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product and Services
Table 30. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. IBA Group Basic Information, Manufacturing Base and Competitors
Table 32. IBA Group Major Business
Table 33. IBA Group Radiopharmaceuticals in Nuclear Medical Product and Services
Table 34. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 36. Lantheus Medical Imaging Major Business
Table 37. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product and Services
Table 38. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Nordion Basic Information, Manufacturing Base and Competitors
Table 40. Nordion Major Business
Table 41. Nordion Radiopharmaceuticals in Nuclear Medical Product and Services
Table 42. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Ntp Radioisotopes Basic Information, Manufacturing Base and Competitors
Table 44. Ntp Radioisotopes Major Business
Table 45. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product and Services
Table 46. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 48. Siemens Healthcare Major Business
Table 49. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product and Services
Table 50. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Taiyo Nippon Sanso Corporation Basic Information, Manufacturing Base and Competitors
Table 52. Taiyo Nippon Sanso Corporation Major Business
Table 53. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product and Services
Table 54. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Urenco Limited Basic Information, Manufacturing Base and Competitors
Table 56. Urenco Limited Major Business
Table 57. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product and Services
Table 58. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Rotem Industries Basic Information, Manufacturing Base and Competitors
Table 60. Rotem Industries Major Business
Table 61. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product and Services
Table 62. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Radiopharmaceuticals in Nuclear Medical Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 64. Global Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Radiopharmaceuticals in Nuclear Medical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Radiopharmaceuticals in Nuclear Medical Production Capacity by Company, (K MT): 2020 VS 2021
Table 67. Head Office and Radiopharmaceuticals in Nuclear Medical Production Site of Key Manufacturer
Table 68. Radiopharmaceuticals in Nuclear Medical New Entrant and Capacity Expansion Plans
Table 69. Radiopharmaceuticals in Nuclear Medical Mergers & Acquisitions in the Past Five Years
Table 70. Global Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2022) & (K MT)
Table 71. Global Radiopharmaceuticals in Nuclear Medical Sales by Region (2023-2028) & (K MT)
Table 72. Global Radiopharmaceuticals in Nuclear Medical Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Radiopharmaceuticals in Nuclear Medical Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2022) & (K MT)
Table 75. Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2023-2028) & (K MT)
Table 76. Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2017-2022) & (USD/MT)
Table 79. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2023-2028) & (USD/MT)
Table 80. Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (K MT)
Table 81. Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2023-2028) & (K MT)
Table 82. Global Radiopharmaceuticals in Nuclear Medical Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Radiopharmaceuticals in Nuclear Medical Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2017-2022) & (USD/MT)
Table 85. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2023-2028) & (USD/MT)
Table 86. North America Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2022) & (K MT)
Table 87. North America Radiopharmaceuticals in Nuclear Medical Sales by Country (2023-2028) & (K MT)
Table 88. North America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2022) & (K MT)
Table 91. North America Radiopharmaceuticals in Nuclear Medical Sales by Type (2023-2028) & (K MT)
Table 92. North America Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (K MT)
Table 93. North America Radiopharmaceuticals in Nuclear Medical Sales by Application (2023-2028) & (K MT)
Table 94. Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2022) & (K MT)
Table 95. Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2023-2028) & (K MT)
Table 96. Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2022) & (K MT)
Table 99. Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2023-2028) & (K MT)
Table 100. Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (K MT)
Table 101. Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2023-2028) & (K MT)
Table 102. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2022) & (K MT)
Table 103. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Region (2023-2028) & (K MT)
Table 104. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2022) & (K MT)
Table 107. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Type (2023-2028) & (K MT)
Table 108. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (K MT)
Table 109. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales by Application (2023-2028) & (K MT)
Table 110. South America Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2022) & (K MT)
Table 111. South America Radiopharmaceuticals in Nuclear Medical Sales by Country (2023-2028) & (K MT)
Table 112. South America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2022) & (K MT)
Table 115. South America Radiopharmaceuticals in Nuclear Medical Sales by Type (2023-2028) & (K MT)
Table 116. South America Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (K MT)
Table 117. South America Radiopharmaceuticals in Nuclear Medical Sales by Application (2023-2028) & (K MT)
Table 118. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2022) & (K MT)
Table 119. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Region (2023-2028) & (K MT)
Table 120. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2022) & (K MT)
Table 123. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Type (2023-2028) & (K MT)
Table 124. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2022) & (K MT)
Table 125. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Application (2023-2028) & (K MT)
Table 126. Radiopharmaceuticals in Nuclear Medical Raw Material
Table 127. Key Manufacturers of Radiopharmaceuticals in Nuclear Medical Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Radiopharmaceuticals in Nuclear Medical Typical Distributors
Table 131. Radiopharmaceuticals in Nuclear Medical Typical Customers
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medical Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type in 2021
Figure 3. Diagnostic Radiopharmaceuticals
Figure 4. Therapy Radiopharmaceuticals
Figure 5. Enriched Stable Isotopes
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application in 2021
Figure 7. Diagnostic Application
Figure 8. Therapeutic Application
Figure 9. Research
Figure 10. Pharmaceutical
Figure 11. Industrial
Figure 12. Global Radiopharmaceuticals in Nuclear Medical Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Radiopharmaceuticals in Nuclear Medical Sales (2017-2028) & (K MT)
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Price (2017-2028) & (USD/MT)
Figure 16. Global Radiopharmaceuticals in Nuclear Medical Production Capacity (2017-2028) & (K MT)
Figure 17. Global Radiopharmaceuticals in Nuclear Medical Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Radiopharmaceuticals in Nuclear Medical Market Drivers
Figure 19. Radiopharmaceuticals in Nuclear Medical Market Restraints
Figure 20. Radiopharmaceuticals in Nuclear Medical Market Trends
Figure 21. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Manufacturer in 2021
Figure 22. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Manufacturer in 2021
Figure 23. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Radiopharmaceuticals in Nuclear Medical Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Radiopharmaceuticals in Nuclear Medical Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2017-2028)
Figure 27. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2017-2028)
Figure 28. North America Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028) & (USD Million)
Figure 29. Europe Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028) & (USD Million)
Figure 31. South America Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue (2017-2028) & (USD Million)
Figure 33. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2017-2028)
Figure 34. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2017-2028)
Figure 35. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2017-2028) & (USD/MT)
Figure 36. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2028)
Figure 37. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2017-2028)
Figure 38. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2017-2028) & (USD/MT)
Figure 39. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2017-2028)
Figure 40. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2028)
Figure 41. North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2017-2028)
Figure 42. North America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2017-2028)
Figure 43. United States Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2017-2028)
Figure 47. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2028)
Figure 48. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2017-2028)
Figure 49. Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2017-2028)
Figure 50. Germany Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2017-2028)
Figure 59. China Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2017-2028)
Figure 66. South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2028)
Figure 67. South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2017-2028)
Figure 68. South America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical in 2021
Figure 80. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure 81. Radiopharmaceuticals in Nuclear Medical Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source